Recent advances in diagnosis and treatment of acute kidney injury in patients with cancer

European Journal of Internal Medicine

Volumn 22, Issue 4, 2011, Pages 348-354

  Denker, Bradley ^a   Robles Osorio, Ma Ludivina ^b   Sabath, Ernesto ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^c Hospital General Querétaro   (Mexico)

Author keywords

Acute kidney injury; Cancer; Chemotherapy; Hematopoietic Stem Cell Transplantation; Multiple Myeloma; Tumor Lysis Syndrome

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; BORTEZOMIB; CALCINEURIN INHIBITOR; CISPLATIN; CONTRAST MEDIUM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; FUROSEMIDE; GEMCITABINE; IFOSFAMIDE; INTERLEUKIN 2; MELPHALAN; METHOTREXATE; MITOMYCIN C; NITROSOUREA; NITROSOUREA DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; TAMOXIFEN; THALIDOMIDE; UNINDEXED DRUG; VINCRISTINE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ACUTE LEUKEMIA; AMYLOIDOSIS; CANCER INFILTRATION; CANCER PATIENT; CANCER THERAPY; CAPILLARY LEAK SYNDROME; CASE NEPHROPATHY; CAST NEPHROPATHY; COMPUTER ASSISTED TOMOGRAPHY; DEHYDRATION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; EARLY DIAGNOSIS; ELDERLY CARE; GLOMERULOPATHY; GLOMERULUS INJURY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATORENAL SYNDROME; HUMAN; HYPERCALCEMIA; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY TUBULE DISORDER; KIDNEY TUBULE OBSTRUCTION; LIVER VENOOCCLUSIVE DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; MULTIPLE MYELOMA; MYELOMA; NEOPLASM; NONHODGKIN LYMPHOMA; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROGNOSIS; PROTEINURIA; REVIEW; RISK FACTOR; THROMBOTIC MICROANGYOPATHY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT PLANNING; TUBULAR DYSFUNCTION; TUMOR LYSIS SYNDROME; TUMOR RECURRENCE; TUMOR VOLUME; UREMIA; URINARY TRACT OBSTRUCTION;

EID: 79960563166     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.02.002     Document Type: Short Survey

References (50)

1. B.D. Humphreys, R.J. Soiffer, and C.C. Magee Renal failure associated with cancer and its treatment: an update J Am Soc Nephrol 16 2005 151 156
2. M. Kleber, M. Cybulla, K. Bauchmuller, G. Ihorst, B. Koch, and M. Engelhardt Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice Ann Oncol 18 2007 950 958 (Pubitemid 47054095)
3. F. Gaspari, P. Cravedi, M. Mandala, N. Perico, F.R. de Leon, and N. Stucchi Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study Nephron Clin Pract 115 2010 154 160
4. V.S. Vaidya, J.S. Ozer, D. Frank, F.B. Collings, V. Ramirez, and S. Troth Kidney Injury Molecule-1 outperforms traditional biomarkers of kidney injury in multi-site preclinical biomarker qualification studies Nat Biotechnol 28 2010 478 485
5. A. Fogo Approach to renal biopsy Am J Kidney Dis 43 2003 826 836
6. P.S. Liu, and J.F. Platt CT angiography of the renal circulation Radiol Clin North Am 48 2010 347 365
7. R.L. Chevalier, and S. Klahr Therapeutic approaches in obstructive uropathy Semin Nephrol 18 1998 652 658 (Pubitemid 28506737)
8. J.R. Wilson, G.H. Urwin, and M.J. Stower The role of percutaneous nephrostomy in malignant ureteric obstruction Ann R Coll Surg Engl 87 2005 21 24 (Pubitemid 40104227)
9. C.J. Diskin, T.J. Stokes, L.M. Dansby, L. Radcliff, T.B. Carter, and E. Graves Acute renal failure due to a primary renal B-cell lymphoma Am J Kidney Dis 50 2007 885 889 (Pubitemid 350027711)
10. Y.K. Wen, and M.L. Chen Acute renal failure secondary to small cell lung cancer with tumor infiltration of the kidneys Ren Fail 28 2006 261 264
11. V. Audard, B. Georges, P. Vanhille, C. Toly, B. Deroure, and F. Fakhouri Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum Clin J Am Soc Nephrol 3 2008 1339 1349
12. S.C. Sengul, C. Zwizinski, and V. Batuman Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells Am J Physiol Renal Physiol 284 2003 1245 1254
13. M.D. Saemann, T. Weichhart, M. Zeyda, G. Staffler, M. Schunn, and KM Stuhlmeier Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism J Clin Invest 115 2005 468 475 (Pubitemid 40385489)
14. M.A. Dimopoulos, E. Kastritis, L. Rosinol, J. Blade, and H. Ludwig Pathogenesis and treatment of renal failure in multiple myeloma Leukemia 22 2008 1485 1493
15. A.A. Chanan-Khan, J.L. Kaufman, J. Mehta, P.G. Richardson, K.C. Miller, and S. Lonial Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study Blood 109 2007 2604 2606 (Pubitemid 46425908)
16. W.F. Clark, A.K. Stewart, G.A. Rock, M. Sternbach, D.M. Sutton, and B.J. Barret Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial Ann Intern Med 143 2005 777 784
17. C. Lefaucheur, B. Stengel, D. Nochy, P. Martel, G.S. Hill, and C. Jacquot Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association Kidney Int 70 2006 1510 1517 (Pubitemid 44527323)
18. V. Audard, F. Larousserie, P. Grimbert, M. Abtahi, J.J. Sotto, and A. Delmer Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature Kidney Int 69 2006 2251 2260 (Pubitemid 43882113)
19. R. Bjørneklett, B.E. Vikse, E. Svarstad, K. Aasarød, L. Bostad, and F. Langmark Long-term risk of cancer in membranous nephropathy patients Am J Kidney Dis 50 2007 396 403 (Pubitemid 47285451)
20. P.M. Ronco Paraneoplastic glomerulopathies: new insights into an old entity Kidney Int 56 1999 355 377 (Pubitemid 29300560)
21. M.A. Gertz, M.Q. Lacy, and A. Dispenzieri Immunoglobulin light chain amyloidosis and the kidney Kidney Int 61 2002 1 9 (Pubitemid 34075125)
22. M. Pecherstorfer, K. Brenner, and N. Zojer Current management strategies for hypercalcemia Trends Endocrinol 2 2003 273 292 (Pubitemid 36935106)
23. A. Lortholary, J. Hon, E. Abdi, G. Mills, H.D. Menssen, and F. Yunus Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled, clinical trials J Clin Oncol 19 2001 558 567 (Pubitemid 32112871)
24. D. Baron, A. Mayo, and Y. Kluger Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease Clin Oncol (R Coll Radiol) 18 2006 90 91 (Pubitemid 43056711)
25. W.H. Kruit, P.I. Schmitz, and G. Stoter The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lympokine-actiavted killer cells Cancer Immunol Immunother 48 1999 331 335 (Pubitemid 29434193)
26. M.A. Papadakis, M.P. Busch, and A.I. Arieff Hepatorenal syndrome complicating chronic lymphocytic leukemia Am J Med 80 1986 320 322 (Pubitemid 16140789)
27. S.M. Gresset, and S.R. Shah Intricacies of bevacizumab-induced toxicities and their management Ann Pharmacother 43 2009 490 501
28. S. Wu, C. Kim, L. Baer, and X. Zhu Bevacizumab increases risk for severe proteinuria in cancer patients J Am Soc Nephrol 21 2010 1381 1389
29. G.S. Markowitz, G.B. Appel, P.L. Fine, A.Z. Fenves, N.R. Loon, and S. Jagannath Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate J Am Soc Nephrol 12 2001 1164 1172 (Pubitemid 32472629)
30. G.S. Markowitz, P.L. Fine, J.I. Stack, C.L. Kunis, J. Radhakrishnan, and W. Palecki Toxic acute tubular necrosis following treatment with zoledronate (Zometa) Kidney Int 64 2003 281 289 (Pubitemid 36714182)
31. C.R. Dunstan, D. Felsenberg, and M.J. Seibel The risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease Nat Clin Pract Oncol 4 2007 42 55 (Pubitemid 46017693)
32. M. Jiang, C.Y. Wang, S. Huang, T. Yang, and Z. Dong Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway Am J Physiol Renal Physiol 296 2009 983 993
33. S.W. Kim, J.U. Lee, M.Y. Nah, D.G. Kang, and K.Y. Ahn Cisplatin decreases the abundance of aquaporin water channels in rat kidney J Am Soc Nephrol 12 2001 875 882
34. J.T. Santoso, J.A. Lucci, R.L. Coleman, I. Schafer, and E.V. Hannigan Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial Cancer Chemother Pharmacol 52 2003 13 18 (Pubitemid 36920623)
35. M.L. Hensley, K.L. Hagerty, T. Kewalramani, D.M. Green, N.J. Meropol, and T.H. Wasserman American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants J Clin Oncol 27 2009 127 145
36. L. Patzer, N. Hernando, U. Ziegler, B. Beck-Schimmer, J. Biber, and H. Murer Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells Kidney Int 70 2006 1725 1734 (Pubitemid 44684803)
37. O. Oberlin, O. Fawaz, A. Rey, P. Niaudet, V. Ridola, and D. Orbach Long-term evaluation of ifosfamide-related nephrotoxicity in children J Clin Oncol 27 2009 5350 5355
38. B.C. Widemann, and P.C. Adamson Understanding and managing methotrexate nephrotoxicity Oncologist 11 2006 694 703 (Pubitemid 43967624)
39. M.S. Cairo, and M. Bishop Tumor lysis syndrome: new therapeutic strategies and classification Br J Haematol 127 2004 3 11 (Pubitemid 39331101)
40. U.M. Khosla, S. Zharikov, J.L. Finch, T. Nakagawa, C. Roncal, and W. Mu Hyperuricemia induces endothelial dysfunction Kidney Int 67 2005 1739 1742 (Pubitemid 40577708)
41. C.L. LaRosa, S. McMullen, D. Bakdash, L. Ellis, H. Krishnamurti, and Y. Wu Acute renal failure from xanthine nephropathy during management of acute leukemia Pediatr Nephrol 22 2007 132 135
42. S.C. Goldman, J.S. Holcenberg, J.Z. Finklestein, R. Hutchinson, S. Kreissman, and F.L. Johnson A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis Blood 97 2001 2998 3003
43. L. Oberic, M. Buffet, M. Schwarzinger, A. Veyradier, K. Clabault, and S. Malot Cancer awareness in atypical thrombotic microangiopathies Oncologist 14 2009 769 779
44. Y. Fujimura, and M. Matsumoto Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008 Intern Med 49 2010 7 15
45. R. Pisoni, P. Ruggenenti, and G. Remuzzi Drug-induced thrombotic microangiopathy Drug Saf 21 2001 491 501
46. R.A. Zager, J. O'Quigley, B.K. Zager, C.E. Alpers, H.M. Shulman, and L.M. Gamelin Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients Am J Kidney Dis 13 1989 210 216 (Pubitemid 19087543)
47. C.R. Parikh, R.W. Schrier, R. Storer, R. Diaconescu, M.L. Sorror, and M.B. Maris Comparison of acute renal failure after myeloablative and nonmyeloablative hematopoietic cell transplantation Am J Kidney Dis 45 2005 502 509 (Pubitemid 40341329)
48. A. Schwarz, H. Haller, R. Schmitt, M. Schiffer, C. Koenecke, and C. Strassburg Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues Am J Transplant 10 2010 2017 2025
49. SL Hu The role of graft versus host disease in hematopoitic cell transplantation-associated glomerular disease Nephrol Dial Transplant 26 2011 2025 2031
50. A. Helmy Updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome Aliment Pharmacol Ther 23 2006 11 25 (Pubitemid 43381162)